The Pathologic Classification of Neuroendocrine Tumors: A Review of Nomenclature, Grading, and Staging Systems

By D. Klimstra, I. Modlin, D. Coppola, R. Lloyd, S. Suster. Pancreas, 2010

1,074 citations recorded by the source corpus.

Subfields: Epidemiology, Neurology, Oncology

View Paper: https://www.semanticscholar.org/paper/c5c450044843c51d10aa7b8332b4c8d838b66de9

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. M. Caplin
2. B. Oronsky
3. P. Ma
4. W. Travis
5. E. Baudin
6. P. Ferolla
7. D. Morgensztern
8. C. Carter

Citations in the corpus

• Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids. (2015, background): “The term neuroendocrine (NE) neoplasm encompasses the whole spectrum of lung tumors characterized by NE morphology and differentiation [1, 2], including well-differentiated and poorly differentiated tumors.”
• Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas (2017, background): “Histology Well-differentiated NET cells, which produce abundant secretory granules with intense immunoexpression of neuroendocrine markers such as chromogranin A (CgA) and synaptophysin (Syn), are characteristically arranged in a well-developed “organoid” or neuroendocrine shape with nesting, trabec”